SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AE6. A total of 63 filers reported holding SALIX PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $25,000 | – | 13,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GRACE BROTHERS MANAGEMENT LLC | 2,800,000 | $5,117,000 | 4.90% |
| SILVERBACK ASSET MANAGEMENT LLC | 18,209,000 | $33,322,000 | 4.30% |
| RAVEN ROCK CAPITAL MANAGEMENT, LLC | 1,000,000 | $1,990,000 | 2.80% |
| Verition Fund Management LLC | 5,504,000 | $10,062,000 | 2.26% |
| CAMDEN ASSET MANAGEMENT L P /CA | 26,798,000 | $48,856,000 | 1.81% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,600,000 | $15,679,000 | 1.60% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 3,000,000 | $5,490,000 | 1.46% |
| BASSO CAPITAL MANAGEMENT, L.P. | 4,825,000 | $8,782,000 | 1.40% |
| Wellesley Asset Management | 12,564 | $23,006,000 | 1.35% |
| WOLVERINE ASSET MANAGEMENT LLC | 31,156,000 | $56,979,000 | 1.11% |